4Vote!
Bloomberg (Free subscription) | 10/30/2009
... during the six months ended Sept. 30 last year, mostly relating to its $8.9 billion purchase of Millennium Pharmaceuticals Inc. Takeda has set up more overseas sales offices including in Mexico and hired an external advisory board as part of efforts to cope with an anticipated decline in revenue from its two best-selling products, Actos and Prevacid. Patent protection will expire...
4Vote!
PR News Wire (Free subscription) | 10/27/2009
CAMBRIDGE, Mass., Oct. 27 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced that Marsha Fanucci has joined its Board of Directors. Ms. Fanucci served at Millennium Pharmaceuticals, Inc. from 2000-2009 in a number of senior positions, including chief financial officer and senior vice president of strategy, vice president of finance and strategy, and vice president of...
3Vote!
Medical News Today (Free subscription) | 10/22/2009
... form of NHL mostly affecting those above 50 years of age. About VELCADEVELCADE is co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Millennium is responsible for commercialization of VELCADE in the U.S., Janssen-Cilag is responsible for commercialization in Europe and the rest of the world. Janssen Pharmaceutical K.K....
